国际标准期刊号: 2155-952X

生物技术与生物材料

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 研究圣经
  • 中国知网(CNKI)
  • 访问全球在线农业研究 (AGORA)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

An Approach to Computer Aided Drug Design of some Bioactive Cinnamoyl Hydrazones, In Silico and Docking Studies as Possible COX-2 Selective Inhibitors

B Haseena Banu, Galla Rajitha2 and K Bharathi

Recently structural analogue-based drug discovery has become an important tool for designing more potent drugs. This study uses SAR, pharmacophore study and structural analogue-based novel drugs to design selective inhibitor molecules using internet-based tools. Substituted acyl hydrazones are known for wide variety of biological activities, such as analgesic, anti–inflammatory, anti-microbial, anti-convulsant, anti-platelet, anti-tubercular, antiviral, schistomiasis and anti-tumoral activities. In the last decade several cinnamic acid derivatives were reported as potent lipoxygenase inhibitors, antioxidants and anti-inflammatory agents. We found it interesting to combine these particular molecules and design cinnamoyl hydrazones, a series of N-[(1E)-2-substituted phenyl-1-{N'-[(1E)-phenyl methylidene] hydrazine carbonyl} eth-1-en-1-yl] benzamides. The designed compounds were predicted for their drug likeness and oral bioavailability. Selected compounds were docked with COX-2 enzyme and found that they were showing similar interactions as that of SC-558, 1000 time selective standard COX-2 inhibitor.